Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY
$7.34
-$0.26-3.42%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 205.10M | 81.46M | 96.15M | 432.28M | 183.27M |
| Total Depreciation and Amortization | -- | 385.72M | -180.26M | 178.43M | -- |
| Total Amortization of Deferred Charges | -- | 46.21M | -24.42M | 24.17M | -- |
| Total Other Non-Cash Items | -351.16M | 480.97M | -222.50M | 322.59M | -486.33M |
| Change in Net Operating Assets | -- | -457.70M | 521.11M | -515.82M | -- |
| Cash from Operations | -146.06M | 536.66M | 190.09M | 441.65M | -303.06M |
| Capital Expenditure | -99.40M | -100.67M | -68.13M | -54.57M | -100.36M |
| Sale of Property, Plant, and Equipment | 15.38M | 3.56M | 1.77M | 7.55M | 1.75M |
| Cash Acquisitions | -- | 53.04M | -4.13M | -84.09M | -2.57M |
| Divestitures | 378.60K | 2.27M | 1.01M | 134.60K | 2.18M |
| Other Investing Activities | 42.15M | -408.46M | 132.35M | 94.01M | -34.77M |
| Cash from Investing | -41.49M | -450.27M | 62.87M | -36.97M | -133.76M |
| Total Debt Issued | 23.21B | 13.30B | 14.29B | 18.72B | 23.07B |
| Total Debt Repaid | -22.12B | -18.29B | -16.25B | -18.06B | -18.63B |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 7.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -120.10M | -60.07M | -211.57M | -37.22M | -81.20M |
| Other Financing Activities | -101.93M | 316.91M | -832.58M | -505.87M | 2.54M |
| Cash from Financing | 22.04M | -719.16M | -601.75M | -15.33M | 531.26M |
| Foreign Exchange rate Adjustments | -1.27M | 1.18M | 323.90K | -2.46M | 555.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -166.78M | -631.59M | -348.47M | 386.89M | 95.00M |